2026 NPPES data Optometrist NPI 1437232246
Verify on CMS →

CLYDE HAWORTH

Optometrist in CUMBERLAND, Rhode Island. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
39
Medicare Part D claims · 12 beneficiaries · Optometrist avg: 257
Generic prescribing
28%
generic claims · 72% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$35.6
2 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: CLYDE HAWORTH is a Optometrist ([object Object]) practicing in CUMBERLAND, Rhode Island with a Medicare Part D prescribing footprint of 39 claims across 12 beneficiaries — 72% brand-name prescribing . Industry payments of $35.6 across 2 transactions are disclosed under CMS Open Payments (Sunshine Act).

What the federal data shows

CLYDE HAWORTH filed 39 Medicare Part D claims in 2023 as a Optometrist in CUMBERLAND, Rhode Island, prescribing 28% generic.

39
Part D claims, 2023
28%
generic prescribing
$35.6
industry payments (Sunshine Act)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

CLYDE HAWORTH at a glance

Quality data not reported

NPI registry status

Active

Issued 10/23/2006

NPI 1437232246

Primary specialty

Optometrist

High-volume

60,463 US NPIs in this specialty

Medicare Part D claims

39 85% vs specialty avg

2023 prescription claims

Specialty avg: 257

Specialty distribution in Rhode Island

How Optometrist compares to other specialties among Rhode Island providers

Rhode Island providers

Optometrist share within Rhode Island

1. Optometrist42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Optometrist share within Rhode Island

Specialty board-certification context

Estimated specialty board-certified rate — Optometrist (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Optometrist ABMS/AOA estimate

Est. board-certified rate (Optometrist) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Optometrist) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

CLYDE HAWORTH is a Optometrist provider practicing in CUMBERLAND, Rhode Island, according to the CMS National Plan and Provider Enumeration System (NPPES). NPI: 1437232246. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

CLYDE HAWORTH appears in the CMS NPPES registry as a Optometrist provider at 2190 MENDON RD, CUMBERLAND, RI, 02864, with a listed phone of (401) 333-0090. NPI 1437232246 was issued on 10/23/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what HAWORTH most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 39 prescription claims written by this provider, covering 12 Medicare beneficiaries and totaling roughly $19K in drug spend, split 72% brand-name and 28% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Optometrist is a high-volume specialty nationwide, with 60,463 enrolled providers across 56 states and an average of 257 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

2190 MENDON RD
CUMBERLAND, RI 02864

Provider Details

NPI 1437232246
Specialty Optometrist
Gender Male
NPI Issued 10/23/2006

Hospital and facility affiliations

Facilities where CLYDE HAWORTH bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

KOCH EYE ASSOCIATES LLP
WARWICK, RI

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for CLYDE HAWORTH. Source: openpaymentsdata.cms.gov.

Total received

$36

Largest payer

Tarsus Pharmaceuticals, Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Brand-heavy

CLYDE HAWORTH — brand share 72.0%
Specialty average (est.)

72% brand-name claims vs 28% generic, on 39 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

39
Total Claims
$19K
Total Drug Cost
12
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
52
Total Day Supply
1,448
Brand vs Generic
72% brand / 28% generic
Brand Drug Cost
$19K
Generic Drug Cost
$369

Patient Demographics

Average Patient Age
72.4 years
Avg HCC Risk Score
0.72
Age Distribution
<65: 0, 65-74: N/A, 75-84: N/A, 85+: N/A

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Restasis
Cyclosporine
14

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Optometrist Overview

How CLYDE HAWORTH fits within the Optometrist landscape nationally.

60,463
Optometrist Providers in US
56
States with Optometrist
257
Avg Claims per Provider

CLYDE HAWORTH's 39 claims are below the specialty average of 257.

Nearby Optometrist Providers in Rhode Island

Other clinicians with the same primary specialty enrolled in Rhode Island, drawn from the same CMS NPPES roster as HAWORTH.

Compare Optometrist nationally: see state-by-state distribution →

Frequently Asked Questions

What is CLYDE HAWORTH's specialty?
CLYDE HAWORTH specializes in Optometrist and practices in CUMBERLAND, Rhode Island.
How much does CLYDE HAWORTH prescribe under Medicare Part D?
In 2023, CLYDE HAWORTH wrote 39 Medicare Part D claims totaling $19K in drug costs for 12 beneficiaries.
Where is CLYDE HAWORTH located?
CLYDE HAWORTH is located at 2190 MENDON RD, CUMBERLAND, RI, 02864. Phone: (401) 333-0090.
What is CLYDE HAWORTH's NPI number?
CLYDE HAWORTH's National Provider Identifier (NPI) is 1437232246, issued on 10/23/2006.
Does CLYDE HAWORTH prescribe more brand-name or generic drugs?
CLYDE HAWORTH's prescribing is 72% brand-name and 28% generic drugs by claim count, with $19K in brand drug costs.
How many Optometrist providers are there in the US?
There are 60,463 Optometrist providers across 56 states in the US. The average Optometrist provider writes 257 Medicare Part D claims per year.
What drugs does CLYDE HAWORTH prescribe most often?
Based on 2023 Medicare Part D data, CLYDE HAWORTH's most frequently prescribed drugs include Restasis. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does CLYDE HAWORTH accept Medicare?
CLYDE HAWORTH appears in CMS Medicare data with 39 Part D claims and 12 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify CLYDE HAWORTH's credentials?
CLYDE HAWORTH's NPI is 1437232246. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology